Kubota Pharmaceutical Holdings Co., Ltd. Logo

Kubota Pharmaceutical Holdings Co., Ltd.

A clinical-stage company developing drugs and devices for ophthalmic diseases.

4596 | T

Overview

Corporate Details

ISIN(s):
JP3266500002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目7番1号

Description

Kubota Pharmaceutical Holdings Co., Ltd., through its subsidiary Kubota Vision Inc., is a clinical-stage company dedicated to developing novel treatments for ophthalmic diseases. Its mission is to translate scientific innovation into a diverse portfolio of drugs and devices to preserve and restore vision for people worldwide. The company's development pipeline features emixustat hydrochloride, a therapeutic candidate for Stargardt disease. In the device segment, Kubota is commercializing Kubota Glass®, a wearable technology designed to manage myopia. The company focuses on creating solutions to address the root causes of blindness and vision impairment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-13 08:03
四半期報告書-第6期第2四半期(令和2年4月1日-令和2年6月30日)
Japanese 216.4 KB
2020-05-14 08:03
四半期報告書-第6期第1四半期(令和2年1月1日-令和2年3月31日)
Japanese 192.9 KB
2020-04-13 07:45
訂正有価証券報告書-第5期(平成31年1月1日-令和1年12月31日)
Japanese 471.7 KB
2020-03-27 03:30
有価証券報告書-第5期(平成31年1月1日-令和1年12月31日)
Japanese 749.2 KB
2019-11-14 08:43
四半期報告書-第5期第3四半期(2019/07/01-2019/09/30)
Japanese 175.2 KB
2019-08-09 08:26
四半期報告書-第5期第2四半期(2019/04/01-2019/06/30)
Japanese 157.7 KB
2019-05-10 08:17
四半期報告書-第5期第1四半期(2019/01/01-2019/03/31)
Japanese 151.0 KB
2019-03-28 08:10
有価証券報告書-第4期(平成30年1月1日-平成30年12月31日)
Japanese 723.0 KB
2018-11-14 07:43
四半期報告書-第4期第3四半期(2018/07/01-2018/09/30)
Japanese 153.2 KB
2018-08-14 08:00
四半期報告書-第4期第2四半期(2018/04/01-2018/06/30)
Japanese 197.4 KB
2018-05-15 08:00
四半期報告書-第4期第1四半期(2018/01/01-2018/03/31)
Japanese 138.3 KB
2018-04-26 09:27
訂正有価証券報告書-第3期(平成29年1月1日-平成29年12月31日)
Japanese 441.4 KB
2018-03-15 07:00
有価証券報告書-第3期(平成29年1月1日-平成29年12月31日)
Japanese 782.9 KB
2017-11-09 07:07
四半期報告書-第3期第3四半期(2017/07/01-2017/09/30)
Japanese 350.2 KB
2017-08-08 08:06
四半期報告書-第3期第2四半期(2017/04/01-2017/06/30)
Japanese 358.1 KB

Automate Your Workflow. Get a real-time feed of all Kubota Pharmaceutical Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kubota Pharmaceutical Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kubota Pharmaceutical Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.